Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page
- CheckyesterdayChange DetectedA site banner announces an NIH website transition and says that some NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer now shows revision v3.7.1 instead of v3.7.0; the study page still displays a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected study details and navigation. This indicates an access issue rather than a substantive update to the study information.SummaryDifference18%

- Check57 days agoChange DetectedAdded '2017 ( U.S. NIH Grant/Contract )' to the study's Other Study ID Numbers, clarifying funding attribution for the trial. Updated the site revision information by adding 'Revision: v3.6.6' and removing 'Revision: v3.6.5' from the footer, reflecting a platform update.SummaryDifference0.2%

- Check78 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4, indicating a minor site update. The study information and visible content remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.